Aeterna Zentaris Receives Agreement from FDA on Special Protocol Assessment for Solorel - AEterna Zentaris (NASDAQ:AEZS)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Aeterna Zentaris Inc. (NASDAQ: AEZS) today announced that it has reached agreement with the Food and Drug Administration on a Special Protocol Assessment for Solorel which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!